Highlights
- •
CRISPR-Cas13a can quantitatively detect SARS-CoV-2 RNA without pre-amplification
- •
Combining crRNAs targeting multiple regions of the viral RNA enhances sensitivity
- •
Cas13a can accurately and rapidly quantify SARS-CoV-2 RNA in patient samples
- •
A mobile phone-based device allows for portable and sensitive read-out of the assay
https://www.cell.com/cell/fulltext/S0092-8674(20)31623-8#.X8w80ReOs3I.twitter